(Q37879017)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

review article

1 reference

title

Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Dustin Pagoria

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R Corey O'Connor

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Current urology reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

351-357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

Defining overactive bladder: epidemiology and burden of disease

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

The problems of anticholinergic adverse effects in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Muscarinic receptor antagonists for overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Astrocyte-endothelial interactions at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

The role of p-glycoprotein in limiting brain penetration of the peripherally acting anticholinergic overactive bladder drug trospium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Psychotic disorder induced by oxybutynin: Presentation of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Using anticholinergics to treat overactive bladder: the issue of treatment tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Transient memory impairment and hallucinations associated with tolterodine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Cognitive dysfunction with tolterodine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Hallucinations with tolterodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Tolterodine and memory: dry but forgetful

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Treatment of overactive bladder in the older patient: pooled analysis of three phase III studies of darifenacin, an M3 selective receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Assessment of cognitive function of the elderly population: effects of darifenacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Comparison of fesoterodine and tolterodine in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Efficacy and tolerability of fesoterodine in older and younger subjects with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Trospium chloride is undetectable in the older human central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0198-9

Darifenacin treatment of patients ≥ 65 years with overactive bladder: results of a randomized, controlled, 12-week trial

21 January 2018

1 reference

12 December 2020

Prevalence and burden of overactive bladder in the United States

1 reference

12 December 2020

Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome

1 reference

12 December 2020

The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations

1 reference

12 December 2020

1 reference

12 December 2020

A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder

1 reference

12 December 2020

Anticholinergic side-effects of drugs in elderly people

1 reference

12 December 2020

10.1007/S11934-011-0198-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607875%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference